SureTrader
Cannabis Stocks News
Interactive Brokers Advertisement
Home > Boards > Free Zone > All Trading - Technical > The Hunt for the Next 10 Bagger

$CNBX DUE DILIGENCE/ 51% of the volume was

Public Reply | Private Reply | Keep | Last ReadPost New MsgReplies (1) | Next 10 | Previous | Next
MjPlayz Member Profile
 
Followed By 19
Posts 881
Boards Moderated 0
Alias Born 10/22/15
160x600 placeholder
MjPlayz   Monday, 03/20/17 08:25:55 AM
Re: MazelTov post# 622225
Post # of 624222 
$CNBX DUE DILIGENCE/ 51% of the volume was SOLD SHORT Sellers Friday
http://otcshortreport.com/?index=CNBX&action=view


1.2Mil of the 14Mil share FLOAT is SHORT


http://shortsqueeze.com/?symbol=Cnbx&submit=Short+Quote%E2%84%A2

THE RISK FACTORS IN THE 10K WERE ALREADY SATISFIED.  IF YOU READ THE MOST RECENT 10Q, THEY ALREADY RAISED ANOTHER $500K ON JANUARY 7TH AND ONLY NEEDED 1 MILLION FOR THE ENTIRE YEAR <2017>

The Company MOST likely SOLD another 500k shares since January 7th, netting them another $1.5 million , which will remove any Going Concern reflected in the 2016 10K which was before the stock ran and pretty much OBSOLETE at this point. 

SHORT SELLERS WANT TO POINT TO OBSOLETE INFORMATION TO CONVINCE OR SCARE PEOPLE INTO SELLING THERE SHARES.    BIG NEWS COMING, ON THE DIAGNOSTIC TESTS AND PHASE 3 TRIAL





CNBX PHASE 3 TRIAL Official Cannabics Capsules as Treatment to Improve Cancer Related Cachexia and Anorexia Syndrome in Advanced Cancer

https://clinicaltrials.gov/ct2/show/NCT02359123

CNBX READ THIS.  SEE THE LINK BELOW.  IMPRESSIVE! Cannabics Pharmaceuticals Announces Initial Commercialization of Cannabinoids-based Personalized Diagnostics for Cancer Patients


http://www.bizjournals.com/prnewswire/press_releases/2017/02/06/LN05175


CNBX Commercialization will commence in March 2017, when 10 first patients' liquid biopsies will be tested using this technology. The company plans to make this service available to cancer patients in Canada, Europe and the USA, under local medical cannabis regulations in each country and state, by the end of the year. Itamar Borochov, CEO of Cannabics Pharmaceuticals, says "We are the first company in the world to offer cancer patients personalized cannabinoid anti-tumor diagnostics. We are excited to be pioneers in the nexus of cannabis and personalized cancer treatments".



http://www.prnewswire.com/news-releases/cannabics-pharmaceuticals-announces-initial-commercialization-of-cannabinoids-based-personalized-diagnostics-for-cancer-patients-300403359.html


A Hard Look at Cannabics Pharmaceuticals Inc $CNBX

http://oracledispatch.com/2017/03/13/hard-look-cannabics-pharmaceuticals-inc-otcmktscnbx/



Public Reply | Private Reply | Keep | Last ReadPost New MsgReplies (1) | Next 10 | Previous | Next
Follow Board Follow Board Keyboard Shortcuts Report TOS Violation
X
Current Price
Change
Volume
Detailed Quote - Discussion Board
Intraday Chart
+/- to Watchlist